Rothman Paul 4
Research Summary
AI-generated summary
Labcorp (LH) Director Paul Rothman Receives 733 RSUs
What Happened
Paul Rothman, a director of Labcorp Holdings, was granted 733 restricted stock units (RSUs) on February 10, 2026. The RSUs were reported as acquired at $0.00 (typical for RSU awards) and represent a contingent right to receive one share of Labcorp common stock per unit. The units vest in full on February 10, 2027.
Key Details
- Transaction date: 2026-02-10; Form 4 filed 2026-02-12 (timely filing).
- Transaction type/code: Award/Grant (A) — 733 RSUs @ $0.00 (derivative award).
- Vesting: All units vest on February 10, 2027 (Footnote F2).
- Aggregate held after grant: 733 RSUs (Footnote F3).
- RSU definition: Each RSU converts to one share of Labcorp common stock upon vesting (Footnote F1).
- Filing includes Exhibit 24 (Power of Attorney). No indication this filing was late.
Context
RSUs are a form of compensation, giving the recipient the right to receive shares (or their cash value) when vesting conditions are met; they do not represent immediate share ownership or an outlay of cash. Awards like this are common for directors and executives and do not necessarily signal a buy or sell decision by the insider.
Loading document...